The average — age-adjusted — rate for all cancers came out at 451 cases per 100,000 people. However, people living in areas with poorer environmental quality were far more likely to suffer, with around 39 extra cases per 100,000 people than in areas of high environmental quality. The increased cancer rates were suffered by both men and women, with prostate and breast cancers showing a strong association.
A bombshell study was published in the Annals of Internal Medicine in early 2017. Danish researchers studied data on more than 1.4 million women aged 35 to 84 between 1980 and 2010. They found that increased screening for breast cancer caught additional cases of small, slow-growing tumors that were unlikely to harm the patient, but it did not catch additional cases of more aggressive and dangerous cancer that were likely to kill the patients.
A cancer diagnosis can throw a person and their loved ones into emotional turmoil. It’s perfectly normal for anyone diagnosed with cancer to go through a whole range of emotions, often several in a day. Coping with cancer can be as difficult emotionally as it is physically, and those feelings may continue through treatment and even years after recovery.
Mayo Clinic researchers develop new tumor-shrinking nanoparticle to fight breast cancer, prevent recurrence
The results show that the newly designed nanoparticle produced potent anti-tumor immune responses to HER2-positive breast cancers. Breast cancers with higher levels of HER2 protein are known to grow aggressively and spread more quickly than those without the mutation.
A shorter course of radiation therapy given to breast cancer patients following mastectomy is safe and effective and cuts treatment time in half. That is according to data from a phase II clinical trial conducted by Rutgers Cancer Institute of New Jersey investigators and other colleagues who examined a hypofractionated regimen given over three weeks versus the traditional six week course of treatment. The work appears in the current online edition of the Journal of Clinical Oncology.
Coping as both a mother and having breast cancer are two difficult challenges. Both require your time, energy, attention and emotional stability. Even though going through breast cancer and raising two young children seems too much to handle, the kids are the ones who helped me survive. When the world seems like a dark place, your children become the light at the end of the tunnel.
Genetic changes that promote cancer can be inherited from our parents if the changes are present in germ cells, which are the reproductive cells of the body (eggs and sperm). Such changes, called germline changes, are found in every cell of the offspring. Cancer-causing genetic changes can also be acquired during one’s lifetime, as the result of errors that occur as cells divide or from exposure to substances, such as certain chemicals in tobacco smoke, and radiation, such as ultraviolet rays from the sun, that damage DNA. Genetic changes that occur after conception are called somatic (or acquired) changes.
Last year,researchers in California launched a clinical trial to test a new approach to breast cancer screening. The Women Informed to Screen Depending on Measures of RiskExit Disclaimer (WISDOM) clinical trial is using several measures, such as safety, to compare annual mammography with a more individualized approach called risk-based screening.
18-year-old Julian Rios Cantu is the designer of the Eva bra: a bra with biosensors inside the lining that can moderate the temperature, texture, blood flow, and coloring of a woman’s breasts. The user only needs to wear the Eva bra for one to two hours per week in order for the apparel to properly monitor the body’s patterns and conditions. All the data is then downloaded by Bluetooth to an app that will alert the user if there is any alarming changes.
Researchers have found a link between environmental quality and cancer incidence across the U.S. “Our study is the first we are aware of to address the impact of cumulative environmental exposures on cancer incidence,” said Dr. Jyotsna Jagai of the University of Illinois, who led the research team.
In order to determine whether chemotherapy will provide any benefit, a key question is what the chances are that the cancer come back or spread to other parts of the body, or metastasize. If a woman is clinically High Risk and MammaPrint Low Risk, the numbers in recent studies indicate that there would likely be no benefit from chemotherapy.
Women who took 81 mg of aspirin at least three times a week were at 16 percent lower risk of developing breast cancer, according to Dr. Leslie Barnstein’ research team at City of Hope, a renowned cancer center in Duarte, California.
A new study shows that women who live in heavily polluted areas may be more likely to have dense breasts, which is a known risk factor for breast cancer.
The study, published in Breast Cancer Research, finds that the chance of having dense breasts rose by 4% for every 1-unit increase in fine particle concentration. (Pollution is measured by the levels of fine particles in the atmosphere.) Dense breasts have always been considered hereditary, but the new study suggests they may due to environmental factors. Additionally, mammograms have a harder time spotting potentially cancerous areas in dense breasts, increasing the likelihood that cancer may go undetected.
For decades, America’s main chemical safety law offered virtually no protection against toxic chemicals that flooded the market. Badly outmoded and outdated, the Toxic Substances Control Act of 1976 could not even restrict a known carcinogen like asbestos. Fortunately, last year, an overwhelming bipartisan majority in Congress passed legislation to reform the law, starting with the review of those first 10 chemicals – among other important responsibilities and actions required under the new law. It’s now up to us to make sure the Trump administration follows through so workers, kids, pregnant women and the rest of us get the protection we deserve.
According to recent studies, mammogram screenings may not lead to fewer deaths but may instead lead to over-diagnosis. The results were based on research where there were high levels of screening. More tumors were diagnosed, but breast cancer death rates were no lower than in areas with fewer screenings. Clearly, if your goal is to adopt early detection as part of your wellness journey, you need to add complementary tools into the mix to balance an over-dependence on mammogram screenings alone. Thermography is a complementary tool for very early detection. Also known as Digital Infrared Thermographic Imaging (DITI), thermography is a non-invasive test of physiology that can alert your doctors to changes that could indicate early stages of breast disease.
Researchers at the University of California-Los Angeles have developed a computer program that can simultaneously detect cancer and identify from a patient’s blood sample where in the body the cancer is located. The scientists call the program CancerLocator, which works by measuring tumor DNA circulating in the blood.
The BRCA genes are the best known, but are involved in only 1 out of 4 cases of breast cancer with a hereditary component. Most breast cancers are not familial. About 70 percent have been considered sporadic. Does that mean they are not genetic? Not at all. Dozens of genes are now known to contribute to breast cancer, most of them in only a small way, probably in concert with other genes and through interaction with the environment. One researcher has speculated that there may be upwards of 100 more such genes still to be found, and not all the ones that look suspicious will turn out to be harmful.
The breast cancer incidence, or the number of cases per 100,000 women, is still lower in developing countries overall than in the West, but death rates from the disease are higher. This may be attributed to later diagnosis and poor access to treatment. By contrast, the rate of breast cancer per 100,000 women is higher in the U.S., Canada, and Europe than it is in developing countries. Conversely, death rates are markedly lower.
Most of the time, rashes are not cancer. However, because they can be a sign of cancer, rashes and skin changes should be examined by a doctor. Detecting breast cancer as early as possible increases the chances of successful treatment and a cure.
In their systematic evaluation of peer-reviewed randomized clinical trials, the researchers assigned letter grades to therapies based on the strength of evidence. A letter grade of “A” indicates that a specific therapy is recommended for a particular clinical indication, and there is high certainty of substantial benefit for the patient.